These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21528806)

  • 1. Sex hormone priming.
    Lanes R
    J Pediatr Endocrinol Metab; 2011; 24(1-2):7-8. PubMed ID: 21528806
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex steroid priming for growth hormone (GH) provocative tests: an endless debate with insufficient solutions.
    Zadik Z
    J Pediatr Endocrinol Metab; 2011; 24(1-2):3-4. PubMed ID: 21528804
    [No Abstract]   [Full Text] [Related]  

  • 3. Not ready for prime time.
    Gumus P; Chalew S
    J Pediatr Endocrinol Metab; 2011; 24(1-2):5-6. PubMed ID: 21528805
    [No Abstract]   [Full Text] [Related]  

  • 4. Pros of priming in the diagnosis of growth hormone deficiency.
    Gonc EN; Ozon A; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2011; 24(1-2):9-11. PubMed ID: 21528807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's commentary: sex hormone priming.
    Laron Z
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):288. PubMed ID: 24716394
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
    Scaroni C; Ceccato F; Rizzati S; Mantero F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and growth hormone deficiency--still a lot to learn.
    Kiess W; Penke M; Pfäffle R; Körner A; Kratzsch J
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):971-3. PubMed ID: 26353173
    [No Abstract]   [Full Text] [Related]  

  • 8. The pros and cons of sex steroid priming in growth hormone stimulation testing.
    Wetterau LA
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1049-55. PubMed ID: 23329747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition to the adult endocrine clinic: testing pituitary function - what tests and when?
    Geffner ME
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S117-21. PubMed ID: 12914739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormone priming for growth hormone stimulation testing in pre- and early adolescent children is evidence based.
    Rosenbloom AL
    Horm Res Paediatr; 2011; 75(1):78-80. PubMed ID: 21252560
    [No Abstract]   [Full Text] [Related]  

  • 11. Is priming with sex steroids useful for defining patients who will benefit from GH treatment?
    De Sanctis V; Soliman AT; Yassin M; Di Maio S
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):284-7. PubMed ID: 24716393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of growth disorders.
    Ali O; Wyatt D
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogens and sex hormones--combination preparations. 1].
    Albrecht IH
    Pharm Prax; 1967; 5():98-107. PubMed ID: 4303703
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing for growth hormone deficiency in children.
    Richmond E; Rogol AD
    Growth Horm IGF Res; 2020 Feb; 50():57-60. PubMed ID: 31865218
    [No Abstract]   [Full Text] [Related]  

  • 15. A boy with "transient" growth hormone deficiency in prepubertal stage despite normal growth hormone secretion in childhood and after puberty.
    Kashimada K; Onishi T; Ono M; Miyai K; Ohta M; Mizutani S
    Endocr J; 2007 Dec; 54(6):1015-9. PubMed ID: 18000342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy.
    Fernández-Pérez L; Nóvoa J; Ståhlberg N; Santana-Farré R; Boronat M; Marrero D; Henríquez-Hernández L; Norstedt G; Flores-Morales A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):800-6. PubMed ID: 19849699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Panhypopituitarism in one identical twin: the effect of hormone replacement].
    Del Canho H; van Alfen-van der Velden J; del Canho R; Otten B
    Ned Tijdschr Geneeskd; 2011; 155(42):A3084. PubMed ID: 22027454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Developmental trends and conformities in the hormone therapy of climacteric disorders].
    Buschbeck H
    Med Klin; 1967 Sep; 62(37):1432-7. PubMed ID: 4298778
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical deterioration after cessation of growth hormone replacement therapy in a young adult with severe growth hormone deficiency.
    Mönig H; Peter M; Partsch CJ; Kloehn S; Arendt T; Sippell WG
    Growth Horm IGF Res; 1998 Oct; 8(5):385-7. PubMed ID: 10984299
    [No Abstract]   [Full Text] [Related]  

  • 20. Anterior pituitary hormone replacement therapy--a clinical review.
    Auernhammer CJ; Vlotides G
    Pituitary; 2007; 10(1):1-15. PubMed ID: 17265188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.